ConductScience.org, home
GPM6A: glycoprotein M6A
API referenceFor AI assistants

Gene · 2823

Papers1,924

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

1 to 20 of 1,924

Download this page as JSON
TitleJournalYearPMIDFound bySource
Development of m6A Readers for Enhanced Recognition In Vitro via Genetic Code Expansion.ACS Chem Biol202642715419PubTator, text miningPubMed
M6A-regulated LncRNA7825 maintains epithelial barrier integrity to restrict bacterial infection.Int Immunopharmacol202642485757PubTator, text miningPubMed
The lncRNA-m6A axis in cancer: a bidirectional regulatory network in tumor progression and therapeutic resistance.J Transl Med202642400056PubTator, text miningPubMed
Pseudorabies virus hijacks JNK to reprogram m6A machinery for sustaining replication.Microbiol Res202642398312PubTator, text miningPubMed
Optimizing NGN2 Dosage Enhances the Neuronal Enrichment of iPSC-Derived Neuronal Cultures.Mol Cell Proteomics202642309337PubTator, text miningPubMed
The YTHDC1-m6A-GADD45B axis promotes chondrogenesis of hPDLSCs via suppressing senescence through p53/p21 signalling pathway.Int J Oral Sci202642297785PubTator, text miningPubMed
m6A-modified ATF4 regulates glucose/lipid metabolism via the Sestrin2/GSK3β axis to alleviate myocardial ischemia-reperfusion injury.J Cardiothorac Surg202642286721PubTator, text miningPubMed
Regulation of trophoblast fusion dysfunction in preeclampsia by the NCK1/EIF3D/PPARG axis.Biol Res202642271516PubTator, text miningPubMed
FTO promotes cancer progression by regulating VGLL4 m6A levels to activate STAT3 signaling in triple-negative breast cancer.J Biol Chem202642264087PubTator, text miningPubMed
FTO-mediated m6A demethylation of BCL6 promotes gastric cancer progression by suppressing ferroptosis.RNA Biol202642262009PubTator, text miningPubMed
METTL14-Mediated RPL13A Expression Regulates Apoptosis and Invasion of Osteosarcoma via the PTEN/PI3K/AKT Signaling Pathway.J Orthop Res202642227596PubTator, text miningPubMed
Machine Learning-Based Identification of Biomarkers for Early-Stage Non-Small Cell Lung Cancer Through Gene Expression Analysis.Int J Mol Sci202642196266PubTator, text miningPubMed
IGF2BP3 Promotes Head and Neck Squamous Cell Carcinoma Progression via the M6A-LDHA-Lactate-H4K8la Axis and E2F2 Activation.Technol Cancer Res Treat202642033450PubTator, text miningPubMed
Structure-based virtual screening, in vitro and in silico analysis identified novel potent m6A demethylase FTO inhibitors as promising neurotherapeutic agents.Eur J Med Chem202642024965PubTator, text miningPubMed
METTL14-dependent m6A modification restrains interferon signaling to prevent myocarditis and dilated Cardiomyopathy.bioRxiv202641993467PubTator, text miningPubMed
METTL16 promotes taxane resistance in Triple-Negative Breast Cancer through m 6 A-dependent translational upregulation of ABCB1.bioRxiv202641959254PubTator, text miningPubMed
N6-methyladenosine modification of MRP7 mRNA modulates its expression and paclitaxel sensitivity in lung cancer-derived A549 cells.Drug Metab Pharmacokinet202641950566PubTator, text miningPubMed
Targeting the RNA-binding motif protein 15 suppresses prostate cancer progression and hormone therapy resistance by promoting androgen receptor degradation.Mol Biomed202641949706PubTator, text miningPubMed
IFIT3 Associates with m⁶A-Modified RNA to Restrict Hepatitis C Virus Infection.bioRxiv202641929069PubTator, text miningPubMed
M6A-dependent upregulation of ZNF460 promotes epithelial-mesenchymal transition and metastasis of gastric cancer through a histone modification-mediated positive feedback loop.Oncogene202641927792PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Next page

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/2823/papers

API referenceFor AI assistants